Glaucoma study findings emphasise need for regular eye checks

July 17, 2020

People with early-stage glaucoma see the contrast of visible objects in a very similar way to people without the condition, a new study has shown.

Research by the University of Bradford (UK) demonstrated that the brain compensates for the changes in the eye caused by glaucoma, when looking at objects with everyday levels of contrast. The findings add to our understanding of why glaucoma patients report few early symptoms of the disease and may not seek testing until their disease is more advanced.

Glaucoma is a common eye condition affecting half a million people in Britain, where the optic nerve which connects the eye to the brain becomes damaged. It develops slowly over many years and affects peripheral vision first. If untreated, glaucoma results in permanent vision loss.

Glaucoma makes it harder to see contrast - the differences between shades of light and dark - so the eyes are less able to detect low contrast objects. But until now it's not been clear if this contrast sensitivity loss means that patients with glaucoma see visible objects in a different way from healthy people.

Now, the University of Bradford team has shown that people with glaucoma see detectable contrast in the same way as healthy patients, despite their measurable vision loss.

In the study, 20 participants with early- to moderate- stage glaucoma had their disease confirmed, and their areas of peripheral vision loss mapped. They were then asked to respond to a screen display of patterned patches. They adjusted the controls until an image in their poor areas of vision looked equally as bright or dim as a central patterned patch. An eye tracker was used to ensure each patient was looking in the correct place before the central patch could be seen. A control group of healthy participants was tested in the same way.

The researchers found that participants with glaucoma didn't see the image as paler, or 'greyed out' in any way; instead they saw it in exactly the same way as people with healthy vision. The results suggest that glaucoma patients' brains are compensating for damage to the optic nerve.

Dr Jonathan Denniss, a qualified optometrist and lecturer at the University of Bradford, led the study. He said: "This underlines why it's so important to get eyes tested routinely so that glaucoma can be picked up before damage is established. It ties in with the fact that people who have glaucoma initially don't report any symptoms: their brains are successfully overcoming a loss of contrast sight."

He added: "It's always struck me as strange that we all accept the need for routine dental checks to maintain the health of our teeth and mouth, but that routine eye checks among the general population are not considered as important. This is a reminder to get your eyes checked regularly, even if they seem to be fine."
The research was funded by the College of Optometrists.

University of Bradford

Related Glaucoma Articles from Brightsurf:

Monitoring glaucoma at home
Glaucoma is a chronic condition that affects cells at the back of the eye.

Study finds novel mechanism that may confer protection against glaucoma
A team of researchers from LSU Health New Orleans Neuroscience Center of Excellence and the University of Copenhagen provides the first evidence that patients with ocular hypertension may exhibit superior antioxidant protection that promotes resistance to the elevated intraocular pressure associated with glaucoma.

AI-supported test for very early signs of glaucoma progression
A new test can detect glaucoma progression 18 months earlier than the current gold standard method, according to results from a UCL-sponsored clinical trial.

New method gives glaucoma researchers control over eye pressure
Neuroscientists have developed a new method that permits continuous regulation of eye pressure without damage, becoming the first to definitively prove pressure in the eye is sufficient to cause and explain glaucoma.

Glaucoma care in prison inmates
Data fromĀ 82 prison inmates treated in a glaucoma clinic at an academic hospital were used in this observational study to report on how treatment and follow-up, including medication adherence, were are managed.

New glaucoma test to help prevent blindness
Researchers have identified 107 genes that increase a person's risk of developing the eye disease glaucoma, and now developed a genetic test to detect those at risk of going blind from it.

Air pollution linked to higher glaucoma risk
Living in a more polluted area is associated with a greater likelihood of having glaucoma, a debilitating eye condition that can cause blindness, finds a new UCL-led study in the UK.

Long-term statin use associated with lower glaucoma risk
A new study brings the connection between statin use and risk of glaucoma into sharper focus.

Health burden of glaucoma has risen worldwide
The health burden of glaucoma has continuously increased around the globe in the past 25 years, according to an Acta Opthalmologica study.

UAlberta scientists first to pinpoint a cause of pigmentary glaucoma
An international team of researchers has identified a gene responsible for the onset of pigmentary glaucoma, which may lead to new therapies for the condition.

Read More: Glaucoma News and Glaucoma Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to